Related Experiment Video
Updated: Jul 17, 2026
07:36
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
[Juvenile Parkinson's disease and recurring prematurity. Case report]
D-E Ha1, G Legendre, J-C Colau
1Service de Gynécologie-Obstétrique, Hôpital Foch, 40, rue Worth, BP 36, 92151 Suresnes cedex, France. de.ha@hopital-foch.org
Gynecologie, Obstetrique & Fertilite
|February 13, 2007
Summary
Pregnancy with Parkinson's disease is rare. This case study shows a patient with juvenile Parkinson's disease experienced no symptom worsening during pregnancy with levodopa and bromocriptine treatment.
Area of Science:
- Neurology
- Reproductive Medicine
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder typically affecting older adults.
- The co-occurrence of Parkinson's disease and pregnancy is exceptionally rare, with limited documented cases in medical literature.
Observation:
- This report details a rare case of pregnancy in a 30-year-old woman diagnosed with juvenile Parkinson's disease.
- The patient's Parkinson's disease symptoms were managed with levodopa and bromocriptine throughout the gestation period.
Findings:
- No significant aggravation of Parkinson's disease symptoms was observed during the pregnancy.
- The pregnancy was complicated by preterm labor, resulting in delivery at 31 weeks of gestation.
Implications:
- This case contributes to the scarce literature on managing Parkinson's disease during pregnancy.
- It suggests that existing PD medications may be safely used without exacerbating symptoms in pregnant patients.
- Further research is warranted to understand the long-term effects and optimal management strategies for pregnancy in women with early-onset Parkinson's disease.
Related Concept Videos
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...